Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
CYANOKIT SERB S.A. Actual shortage 5G Updated Report 2025-03-24 253207
NRA-URSODIOL NORA PHARMA INC Actual shortage 250MG Updated Report 2025-03-24 248677
NRA-URSODIOL NORA PHARMA INC Actual shortage 500MG Updated Report 2025-03-24 248680
NRA-BETAHISTINE NORA PHARMA INC Actual shortage 8MG Updated Report 2025-03-24 248494
EPINEPHRINE INJECTION USP HIKMA CANADA LIMITED Anticipated shortage 1MG New Report 2025-03-24 253333
TESTOSTERONE ENANTHATE INJECTION, USP HIKMA CANADA LIMITED Actual shortage 200MG Updated Report 2025-03-24 249532
JAMP-LOSARTAN JAMP PHARMA CORPORATION Actual shortage 50MG Updated Report 2025-03-24 221985
SOFRACORT CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 0.05MG 0.5MG 5MG Updated Report 2025-03-24 242064
ONE-ALPHA CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 2MCG Updated Report 2025-03-24 247425
RYTHMODAN CHEPLAPHARM ARZNEIMITTEL GMBH Actual shortage 100MG Updated Report 2025-03-24 248525

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 0.2% New Report 2025-03-24 253342
BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 0.2% New Report 2025-03-24 253339
LATANOPROST OPHTHALMIC SOLUTION HIKMA CANADA LIMITED To be discontinued 50MCG New Report 2025-03-24 253336
TEVA-FINGOLIMOD TEVA CANADA LIMITED Discontinued 0.5MG New Report 2025-03-20 253186
TEVA-PAROXETINE TEVA CANADA LIMITED Discontinued 10MG New Report 2025-03-20 253182
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 40MG New Report 2025-03-20 253177
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 20MG New Report 2025-03-20 253174
TEVA-PRAVASTATIN TEVA CANADA LIMITED Discontinued 10MG New Report 2025-03-20 253171
TEVA-DICLOFENAC-K TEVA CANADA LIMITED Discontinued 50MG New Report 2025-03-20 253168
TEVA-MIRTAZAPINE TEVA CANADA LIMITED Discontinued 30MG New Report 2025-03-20 253165